Jacobs Levy Equity Management
ACGN

Jacobs Levy Equity Management’s Aceragen Inc ACGN Stock Holding History

Jacobs Levy Equity Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,264
Closed -$293K – 1143
2021
Q1 		$293K Buy
13,264
+11,116
+518% +$833K ﹤0.01% 931
2020
Q4 		$134K Sell
2,148
-4,865
-69% -$279K ﹤0.01% 984
2020
Q3 		$255K Buy
7,013
+830
+13% +$29.5K ﹤0.01% 917
2020
Q2 		$188K Buy
6,183
+490
+9% +$15.1K ﹤0.01% 962
2020
Q1 		$128K Sell
5,693
-3,568
-39% -$96.9K ﹤0.01% 942
2019
Q4 		$286K Buy
+9,261
New +$344K ﹤0.01% 864

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Jacobs Levy Equity Management's ACGN Position: Q2 2021 in Review

Jacobs Levy Equity Management sold out of Aceragen Inc (ACGN) in Q2 2021, closing a stake of 13,264 shares — an estimated $293K sold.

Jacobs Levy Equity Management first reported a position in ACGN in Q4 2019 and held it in 6 quarters. The position peaked at $293K in Q1 2021. 47 funds tracked by Wall St. Rank hold ACGN as of Q2 2021.

  • Jacobs Levy Equity Management reported no remaining Aceragen Inc position as of Q2 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 13,264 Aceragen Inc shares in Q2 2021, an estimated $293K.
  • Jacobs Levy Equity Management first reported a position in Aceragen Inc in Q4 2019 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Aceragen Inc position peaked at $293K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.